Abstract: This letter presents a novel method for environmental exploration that takes safety into account in unknown areas by using recursive Gaussian process regression (RGPR). Safety in unknown ...

We didn’t just track DX headlines in 2025 — we traveled to get the context behind them. Here’s what stood up to reality. By the end of 2025, the digital experience industry had moved past the most ...

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

Although something that’s taken for granted these days, the ability to perform floating-point operations in hardware was, for the longest time, something reserved for people with big wallets. This ...

is editor-in-chief of The Verge, host of the Decoder podcast, and co-host of The Vergecast. Today, I’m talking with Prashanth Chandrasekar, who is the CEO of Stack Overflow. I last had Prashanth on ...

U.S. Secretary of State Marco Rubio officially ordered the U.S. State Department to revert to using the Times New Roman font instead of Calibri, The New York Times reported Tuesday. The outlet cited ...

Clang keeps a large fixed-size local array in the stack frame of a recursive function alive across recursive calls, even though the array is only used after both recursive calls return and its address ...

Stack Exchange Inc., the company behind the leading developer resource Stack Overflow, today announced the public launch of its new AI Assist feature. The company says it provides users with access to ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

The researchers used mouse skin samples to monitor changes to the fat tissue under the skin, as well as to the hair follicles and the cells that help hair grow, after they caused small injuries to ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...